Posted on November 1, 2011 by Sitemaster
Accoring to a Bloomberg Businessweek report and information on the Exelixis corporate web site, the company is planning two multi-center, randomized, Phase III clinical trials of the investigational agent cabozantinib (a.k.a., XL184) in metastatic, castration-resistant prostate cancer (mCRPC): … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: cabozantinib, mCRPC, pain, Phase III, trial | Leave a comment »
Posted on September 26, 2011 by Sitemaster
According to another study presented at the European Multidisciplinary Cancer Congress (EMCC) in Stockholm this weekend, the bone-strengthening bisphosphonate ibandronate (Boniva®) seems to work just as well as radiotherapy for the management of pain associated with prostate cancer that has metastasized to the bones. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: Boniva, ibandronate, pain, radiation therapy, skeletal-related event, SRE, zoledronate | Leave a comment »
Posted on September 19, 2011 by Sitemaster
The Phase III SATURN clinical trial of OGX-011 in treatment of men with metastatic, castration-resistant prostate cancer (mCRPC) after initial chemotherapy with docetaxel + prednisone required men to be randomized to either docetaxel + prednisone + OGX-011 or to docetaxel + prednisone + a placebo. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cabazitaxel, custirsen, docetaxel, OGX-011, pain, SATURN, survival, synergy | Leave a comment »
Posted on December 17, 2010 by Sitemaster
It has come to our attention that the American Society for Radiation Oncology (ASTRO) has developed new guidance on the use of palliative external beam radiation therapy (EBRT) for the management of pain associated with metastasis of cancer to bone — a relatively common problem in late stage, metastatic prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, guideline, metastasis, pain, palliation, radiation | Leave a comment »
Posted on April 25, 2009 by Sitemaster
So before I run out the door to get my plane to Chicago, here are non-AUA reports on:
- Perspectives on applications of PSA data in diagnostic profiling
- The adverse events of androgen deprivation therapy
- Potential new form of pain management in very late stage disease … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, capecitabine, Diagnosis, pain, prognosis, PSA, rhenium-188 | 1 Comment »
Posted on April 22, 2009 by Sitemaster
Today’s news reports deal with:
- A gene modification that may identify risk for prostate cancer
- Dietary intervention and prostate cancer management
- “Elastography” as a possible means to assess risk for prostate cancer
- Pain management in very late stage disease … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diet, elastography, gene, pain, predisposition, rs10993994, SNP | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 